Literature DB >> 25651182

MAFG is a transcriptional repressor of bile acid synthesis and metabolism.

Thomas Q de Aguiar Vallim1, Elizabeth J Tarling2, Hannah Ahn2, Lee R Hagey3, Casey E Romanoski4, Richard G Lee5, Mark J Graham5, Hozumi Motohashi6, Masayuki Yamamoto7, Peter A Edwards8.   

Abstract

Specific bile acids are potent signaling molecules that modulate metabolic pathways affecting lipid, glucose and bile acid homeostasis, and the microbiota. Bile acids are synthesized from cholesterol in the liver, and the key enzymes involved in bile acid synthesis (Cyp7a1, Cyp8b1) are regulated transcriptionally by the nuclear receptor FXR. We have identified an FXR-regulated pathway upstream of a transcriptional repressor that controls multiple bile acid metabolism genes. We identify MafG as an FXR target gene and show that hepatic MAFG overexpression represses genes of the bile acid synthetic pathway and modifies the biliary bile acid composition. In contrast, loss-of-function studies using MafG(+/-) mice causes de-repression of the same genes with concordant changes in biliary bile acid levels. Finally, we identify functional MafG response elements in bile acid metabolism genes using ChIP-seq analysis. Our studies identify a molecular mechanism for the complex feedback regulation of bile acid synthesis controlled by FXR.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651182      PMCID: PMC4317590          DOI: 10.1016/j.cmet.2015.01.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  46 in total

1.  Identification of a chemical tool for the orphan nuclear receptor FXR.

Authors:  P R Maloney; D J Parks; C D Haffner; A M Fivush; G Chandra; K D Plunket; K L Creech; L B Moore; J G Wilson; M C Lewis; S A Jones; T M Willson
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

Review 2.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

3.  Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity.

Authors:  Florence Ying Lee; Thomas Quad de Aguiar Vallim; Hansook Kim Chong; Yanqiao Zhang; Yaping Liu; Stacey A Jones; Timothy F Osborne; Peter A Edwards
Journal:  Mol Endocrinol       Date:  2010-06-23

4.  Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.

Authors:  Jonathan Y Bass; Justin A Caravella; Lihong Chen; Katrina L Creech; David N Deaton; Kevin P Madauss; Harry B Marr; Robert B McFadyen; Aaron B Miller; Wendy Y Mills; Frank Navas; Derek J Parks; Terrence L Smalley; Paul K Spearing; Dan Todd; Shawn P Williams; G Bruce Wisely
Journal:  Bioorg Med Chem Lett       Date:  2010-12-23       Impact factor: 2.823

5.  Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

Authors:  M Ananthanarayanan; N Balasubramanian; M Makishima; D J Mangelsdorf; F J Suchy
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

6.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

7.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

8.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

9.  Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.

Authors:  Hansook Kim Chong; Aniello M Infante; Young-Kyo Seo; Tae-Il Jeon; Yanqiao Zhang; Peter A Edwards; Xiaohui Xie; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

10.  Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine.

Authors:  Ann M Thomas; Steven N Hart; Bo Kong; Jianwen Fang; Xiao-Bo Zhong; Grace L Guo
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

View more
  37 in total

1.  Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.

Authors:  Ting Liu; Heping Yang; Wei Fan; Jian Tu; Tony W H Li; Jiaohong Wang; Hong Shen; JinWon Yang; Ting Xiong; Justin Steggerda; Zhenqiu Liu; Mazen Noureddin; Stephanie S Maldonado; Alagappan Annamalai; Ekihiro Seki; José M Mato; Shelly C Lu
Journal:  Gastroenterology       Date:  2018-05-05       Impact factor: 22.682

Review 2.  Small Maf proteins (MafF, MafG, MafK): History, structure and function.

Authors:  Fumiki Katsuoka; Masayuki Yamamoto
Journal:  Gene       Date:  2016-04-05       Impact factor: 3.688

3.  An integrative systems genetic analysis of mammalian lipid metabolism.

Authors:  Benjamin L Parker; Anna C Calkin; Marcus M Seldin; Michael F Keating; Elizabeth J Tarling; Pengyi Yang; Sarah C Moody; Yingying Liu; Eser J Zerenturk; Elise J Needham; Matthew L Miller; Bethan L Clifford; Pauline Morand; Matthew J Watt; Ruth C R Meex; Kang-Yu Peng; Richard Lee; Kaushala Jayawardana; Calvin Pan; Natalie A Mellett; Jacquelyn M Weir; Ross Lazarus; Aldons J Lusis; Peter J Meikle; David E James; Thomas Q de Aguiar Vallim; Brian G Drew
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

4.  β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue.

Authors:  Emmanuel Somm; Hugues Henry; Stephen J Bruce; Sébastien Aeby; Marta Rosikiewicz; Gerasimos P Sykiotis; Mohammed Asrih; François R Jornayvaz; Pierre Damien Denechaud; Urs Albrecht; Moosa Mohammadi; Andrew Dwyer; James S Acierno; Kristina Schoonjans; Lluis Fajas; Gilbert Greub; Nelly Pitteloud
Journal:  JCI Insight       Date:  2017-04-20

5.  Effects of Sleeve Gastrectomy on Serum 12α-Hydroxylated Bile Acids in a Diabetic Rat Model.

Authors:  Minggang Wang; Qunzheng Wu; Haibin Xie; Yi Shao; Mingwei Zhong; Xiang Zhang; Shaozhuang Liu; Xiao He; Sanyuan Hu; Guangyong Zhang
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

Review 6.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

7.  Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases.

Authors:  John Y L Chiang
Journal:  Hepatology       Date:  2015-07-30       Impact factor: 17.425

8.  Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Authors:  Amar Bahadur Singh; Bin Dong; Fredric B Kraemer; Yanyong Xu; Yanqiao Zhang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

9.  Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters.

Authors:  Bin Dong; Mark Young; Xueqing Liu; Amar Bahadur Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2016-12-09       Impact factor: 5.922

10.  MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.

Authors:  Young-Chae Kim; Hyunkyung Jung; Sunmi Seok; Yang Zhang; Jian Ma; Tiangang Li; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.